Sequoia Financial Advisors LLC Has $641,000 Stake in Humana Inc. $HUM

Sequoia Financial Advisors LLC trimmed its position in Humana Inc. (NYSE:HUM) by 39.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,698 shares of the insurance provider’s stock after selling 2,386 shares during the period. Sequoia Financial Advisors LLC’s holdings in Humana were worth $641,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Montag A & Associates Inc. raised its position in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the last quarter. CoreCap Advisors LLC lifted its stake in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac acquired a new position in Humana during the 4th quarter worth approximately $27,000. Reflection Asset Management acquired a new position in Humana during the 4th quarter worth approximately $29,000. Finally, Larson Financial Group LLC grew its stake in shares of Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after acquiring an additional 81 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Price Performance

NYSE:HUM opened at $400.51 on Monday. The stock has a market capitalization of $48.09 billion, a PE ratio of 42.84, a P/E/G ratio of 2.16 and a beta of 0.71. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88. The firm has a fifty day simple moving average of $354.03 and a 200 day simple moving average of $260.20. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, research analysts expect that Humana Inc. will post 9.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on HUM. Needham & Company LLC initiated coverage on shares of Humana in a report on Wednesday, May 20th. They issued a “buy” rating on the stock. TD Cowen raised their target price on shares of Humana from $211.00 to $350.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Oppenheimer upgraded shares of Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday, May 20th. Raymond James Financial set a $300.00 price objective on shares of Humana in a research note on Tuesday, July 7th. Finally, Barclays raised their price objective on Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $325.87.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.